Why Indian pharma cos are gung-ho about the US mkt

While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products. Illustration: Uttam Ghosh/Rediff.com......

Dr Reddy's A-team moves on putting house in order

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set......

India Inc's foreign borrowings down 40%

No new capacity addition is planned for 2018 and capital expenditure plans are on hold Indian companies raised 40 per cent less in foreign currency loans this year till date at $13.5 billion......

What exactly is wrong with India's pharma companies?

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation. The number of class action lawsuits filed against Indian pharmaceutical companies has gone up in recent......